In Reply

Affiliations

Comment

Mohammad Ahmed Maher et al. Obstet Gynecol. 2017 Nov.

. 2017 Nov;130(5):1157-1158.

doi: 10.1097/AOG.0000000000002340.

¹ Department of Obstetrics and Gynaecology, Faculty of Medicine, Menoufia University, Al Minufya, Egypt.

No abstract available

Comment on

Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial.
Maher MA, Sayyed TM, Elkhouly N. Maher MA, et al. Obstet Gynecol. 2017 Apr;129(4):615-620. doi: 10.1097/AOG.0000000000001928. Obstet Gynecol. 2017. Retraction in: Obstet Gynecol. 2020 Apr;135(4):980. doi: 10.1097/AOG.0000000000003836. PMID: 28277352 Retracted. Clinical Trial.
Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial.
Mol BW, Walker SP. Mol BW, et al. Obstet Gynecol. 2017 Nov;130(5):1157. doi: 10.1097/AOG.0000000000002339. Obstet Gynecol. 2017. PMID: 29064958 No abstract available.

1. Maher MA, Sayyed TM, Elkhouly N. Sildenafil citrate therapy for oligohydramnios: a randomized controlled trial. Obstet Gynecol 2017;129:615–20.
1. Sovio U, White IR, Dacey A, Pasupathy D, Smith GC. Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study. Lancet 2015;386:2089–97.
1. Hayward I, Malcoe LH, Cleathero LA, Janssen PA, Lanphear BP, Hayes MV, et al. Investigating maternal risk factors as potential targets of intervention to reduce socioeconomic inequality in small for gestational age: a population-based study. BMC Public Health 2012;12:333.